NCT06715982 2025-10-28
JAK Inhibitors for Solid Malignant Tumor Patients With Immune Checkpoint Inhibitors-related Dermatitis: A Open-lable, Single Arm, Phase IIa Trial
Hangzhou Cancer Hospital
Phase 2 Recruiting
Clinical Trials
1 trialsImmune Checkpoint Inhibitors (ICI)-Related Dermatitis × Janus Kinase Inhibitors × 1 year × Clear all